Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double‐blind, parallel group, randomized controlled trial-Reference-Cited by-同舟云学术

Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double‐blind, parallel group, randomized controlled trial

Published:2020-07-27 Issue:6 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Podder Indrashis¹^ORCID,Das Anupam²^ORCID,Ghosh Shouvik²,Biswas Debalina²,Sengupta Sujata²,Chowdhury Satyendra Nath¹

Affiliation:

1. Department of Dermatology College of Medicine and Sagore Dutta Hospital Kamarhati West Bengal India

2. Department of Dermatology KPC Medical College and Hospital Kolkata West Bengal India

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13946

Reference17 articles.

1. Chronic Spontaneous Urticaria: The Devil's Itch

2. Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study

3. Consensus statement for the diagnosis and treatment of urticaria: A 2017 update

4. Bilastine for the treatment of urticaria

5. Bilastine: A novel antihistamine

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing the clinical efficacy and safety of levocetirizine based on its receptor occupancy, intraclass comparison and role in the treatment of CSU: an AROG consensus statement;Expert Review of Clinical Pharmacology;2024-09-12

2. Exploring the safety profile of bilastine in chronic spontaneous urticaria: A real-world analysis in the Indian population;Indian Journal of Dermatology, Venereology and Leprology;2024-07-11

3. Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement;International Journal of Dermatology;2024-07-04

4. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema;Journal of the European Academy of Dermatology and Venereology;2024-06-10

5. Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial;Chinese Medical Journal;2024-04-01